Drug pricing initiatives during the Trump presidency
4:57
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
Tom Bulleit, Ropes & Gray health care partner, discusses the Trump Administration’s latest drug pricing initiatives.
Trending Similar Videos
-
Section 101: confusion over patentable subject matter
5:11
Matt Rizzolo, Ropes & Gray IP litigation partner, addresses the ongoing confusion over what constitutes patentable subject matter under Section 101 of the Patent Act.
-
Behavioral sciences approach to risk management
3:43
Amanda Raad, co-chair of Ropes & Gray’s anti-corruption & international risk practice, discusses the new data-driven behavioral sciences approach to risk management.
-
SEC activity with fixed income and credit funds
2:51
Dan O’Connor, co-leader of Ropes & Gray’s securities & futures enforcement practice, addresses the recent uptick in how the SEC is approaching issues at fixed income and credit funds.
